glp 1 agonist lilly Medscape | Orforglipron, Eli Lilly's investigational oral glucagon-like peptide receptor (GLP-1 RA), achieved positive phase 3 results for Novel oral GLP-1 receptor agonist
Description
Modulation of glucagon receptor pharmacology by receptor activity-modifying protein-2 (RAMP2) J
[PubMed ID: 24531224]
GIP, Glucose-Dependent Insulinotropic Polypeptide
Liraglutide associated acute pancreatitis: a case report and review of the literature: 1342
Journal of Managed Care & Specialty Pharmacy
Gallstones and biliary sludge are known triggers for acute pancreatitis, potentially creating an indirect pathway between these medications and pancreatic inflammation in some patients
